ASH 2021 Conference Coverage on VuMedi

 

ASH 2021 Conference Coverage on VuMedi
E

ASH 2021 Highlights on Treatment Options for AL Amyloidosis Patients Ineligible for Autologous Transplantation

By ASH 2021 Conference Coverage on VuMedi FEATURING Efstathios Kastritis
By ASH 2021 Conference Coverage on VuMedi FEATURING Efstathios Kastritis
103 views
December 20, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip
Myeloma
05:27

ASH 2021 Sustained Improvement in HRQoL in Transplant-Ineligible Pat…

ASH 2021 Conference Coverage on VuMedi

A. Perrot

83 views
10:50

ASH 2021 Updates on the Efficacy and Safety of Cilta-Cel in R/R MM: …

ASH 2021 Conference Coverage on VuMedi

A. Jakubowiak

187 views
13:38

2022 Updates on CAR T-Cell Therapy for Myeloma

ASH 2021 Conference Coverage on VuMedi

L. Anderson

43 views
05:57

ASH 2021 Update on the Impact of EPd on HRQoL for Patients With R/R …

ASH 2021 Conference Coverage on VuMedi

K. Weisel

295 views
05:25

ASH 2021 on the Efficacy and Safety of Cilta-cel in Len-Refractory P…

ASH 2021 Conference Coverage on VuMedi

Y. C. Cohen

61 views
08:31

ASH 2021 Updated Results From the Phase I CRB-402 Study of the BCMA-…

ASH 2021 Conference Coverage on VuMedi

N. S. Raje

13 views
16:29

ASH 2021 Review of MRD in MM: Why, When, Where, and How?

ASH 2021 Conference Coverage on VuMedi

N. S. Raje

179 views
13:12

ASH 2021: Addressing Current Questions and Controversies in the Mana…

ASH 2021 Conference Coverage on VuMedi

M. Gertz

388 views
07:41

ASH 2021 Update on Cilta-Cel for Triple-Class Exposed MM: Adjusted C…

ASH 2021 Conference Coverage on VuMedi

M. Mateos

121 views
04:34

ASH 2021 on the Safety, Tolerability, PK/PD, and Preliminary Efficac…

ASH 2021 Conference Coverage on VuMedi

N. Shah

64 views
04:19

ASH 2021: Risk of Infections With BCMA-Directed Immunotherapy in Mul…

ASH 2021 Conference Coverage on VuMedi

M. Mohan

85 views
07:00

ASH 2021 Updates on Outcomes in HR-MM Treated With Daratumumab

ASH 2021 Conference Coverage on VuMedi

F. van Rhee

116 views
13:23

ASH 2021 Highlights on Treatment Options for AL Amyloidosis Patients…

ASH 2021 Conference Coverage on VuMedi

E. Kastritis

103 views
09:07

ASH 2021: Genomic and Immune Signatures Predict Sustained MRD Negati…

ASH 2021 Conference Coverage on VuMedi

E. Boyle

166 views
06:08

ASH 2021 Update on the Efficacy and Safety of Ruxolitinib and Steroi…

ASH 2021 Conference Coverage on VuMedi

J. Berenson

123 views
11:03

ASH 2021 Lecture on Clinical Outcomes of R/R MM Patients Following T…

ASH 2021 Conference Coverage on VuMedi

T. Mouhieddine

73 views